These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 37104299)

  • 21. Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort.
    Itamochi M; Yazawa S; Inasaki N; Saga Y; Yamazaki E; Shimada T; Tamura K; Maenishi E; Isobe J; Nakamura M; Takaoka M; Sasajima H; Kawashiri C; Tani H; Oishi K
    Vaccine; 2023 Mar; 41(13):2234-2242. PubMed ID: 36858871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A cross-sectional study.
    Koirala A; McRae J; Britton PN; Downes M; Prasad SA; Nicholson S; Winkler NE; O'Sullivan MVN; Gondalwala F; Castellano C; Carey E; Hendry A; Crawford N; Wadia U; Richmond P; Marshall HS; Clark JE; Francis JR; Carr J; Bartlett A; McMullan B; Skowno J; Hannah D; Davidson A; von Ungern-Sternberg BS; Lee-Archer P; Burgoyne LL; Waugh EB; Carlin JB; Naing Z; Kerly N; McMinn A; Hunter G; Heath C; D'Angelo N; Finucane C; Francis LA; Dougherty S; Rawlinson W; Karapanagiotidis T; Cain N; Brizuela R; Blyth CC; Wood N; Macartney K
    PLoS One; 2024; 19(9):e0300555. PubMed ID: 39292730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
    Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
    Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study.
    Seery V; Raiden S; Russo C; Borda M; Herrera L; Uranga M; Varese A; Marcó Del Pont M; Chirino C; Erramuspe C; Álvarez LS; Lenoir M; Morales LD; Davenport C; Alarcón Flores A; Huespe Auchter S; Ruiz Y; Monsalvo L; Sastoque L; Gavazzi M; Mazzitelli I; Di Diego F; Longueira Y; Mazzitelli B; Sananez I; De Carli N; Biglione MM; Gómez Penedo JM; Ceballos A; Laufer N; Ferrero F; Geffner J; Arruvito L
    EBioMedicine; 2022 Sep; 83():104230. PubMed ID: 35988465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
    Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022.
    Yamayoshi S; Iwatsuki-Horimoto K; Okuda M; Ujie M; Yasuhara A; Murakami J; Duong C; Hamabata T; Ito M; Chiba S; Kobayashi R; Takahashi S; Mitamura K; Hagihara M; Shibata A; Uwamino Y; Hasegawa N; Ebina T; Izumi A; Kato H; Nakajima H; Sugaya N; Seki Y; Iqbal A; Kamimaki I; Yamazaki M; Kawaoka Y; Furuse Y
    Emerg Infect Dis; 2022 Nov; 28(11):2198-2205. PubMed ID: 36198306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among unvaccinated children of Chandigarh, Northwest India, in a household-based paediatric serosurvey post-second wave of pandemic (June to July 2021).
    Ghosh A; Goyal K; Singh R; Lakshmi PVM; Kaur R; Kumar V; Muralidharan J; Puri GD; Ram J; Singh MP
    Public Health; 2023 Dec; 225():160-167. PubMed ID: 37931485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
    Janha RE; Bah A; Jah H; Touray F; Idris Y; Keita S; Gaye Y; Jallow S; Faye-Joof T; Njie B; Craik R; Mohammed NI; von Dadelszen P; D'Alessandro U; Roca A;
    Int J Infect Dis; 2023 Oct; 135():109-117. PubMed ID: 37586660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study.
    Rouge Elton PA; Schmitt PA; Faouzi M; Zimmermann P; Ritter Schenk C
    Swiss Med Wkly; 2022 May; 152():w30173. PubMed ID: 35748747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India.
    Agarwal D; Patil R; Roy S; Kaur H; Mehandale S; Bavdekar A; Nair H; Juvekar S; Dayma G;
    J Glob Health; 2023 Apr; 13():06011. PubMed ID: 37079274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal Randomized Cohort Study of SARS-CoV-2 Antibody Seroprevalence in the St. Petersburg Population.
    Smirnov VS; Lyalina LV; Milichkina AM; Khamitova IV; Zueva EV; Ivanov VA; Zaguzov VS; Totolian AA
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection.
    Kim HM; Lee EJ; O SW; Choi YJ; Lee H; Oh SJ; Kim JM; Park AK; Kim JA; Lee CY; Kim JM; Park H; Park YJ; Yu JH; Kim EY; Ko HP; Kim EJ
    Viral Immunol; 2023 Apr; 36(3):203-208. PubMed ID: 36951666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
    Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
    PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort.
    Smoot K; Yang J; Tacker DH; Welch S; Khodaverdi M; Kimble W; Wen S; Amjad A; Marsh C; Perrotta PL; Hodder S
    JAMA Netw Open; 2022 Sep; 5(9):e2231334. PubMed ID: 36098966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 seroepidemiology in Mongolia, 2020-2021: a longitudinal national study.
    Chimeddorj B; Bailie CR; Mandakh U; Price DJ; Bayartsogt B; Meagher N; Altanbayar O; Magvan B; Deleg Z; Gantumur A; Byambaa O; Nyamdavaa E; Enkhtugs K; Munkhbayar U; Bayanjargal B; Badamsambuu T; Dashtseren M; Amartuvshin T; Narmandakh Z; Togoo K; Boldbaatar EA; Bat-Erdene A; Chimeddorj U; Nyamdavaa K; Tsevegmid E; Batjargal O; Enebish O; Enebish G; Batchuluun B; Zulmunkh G; Byambatsogt G; Enebish T; Le LV; Bergeri I; McVernon J; Erkhembayar R
    Lancet Reg Health West Pac; 2023 Apr; 36():100760. PubMed ID: 37360871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
    Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study.
    To KK; Cheng VC; Cai JP; Chan KH; Chen LL; Wong LH; Choi CY; Fong CH; Ng AC; Lu L; Luo CT; Situ J; Chung TW; Wong SC; Kwan GS; Sridhar S; Chan JF; Fan CY; Chuang VWM; Kok KH; Hung IF; Yuen KY
    Lancet Microbe; 2020 Jul; 1(3):e111-e118. PubMed ID: 33230504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.